restart

The Centers for Disease Control and Prevention and the Food and Drug Administration lifted the pause on the Johnson & Johnson COVID-19 vaccine on April 23, 2021, but the labels and fact sheets given to patients will carry a warning about the exceedingly low risk of developing blood clots. Also, close monitoring of the J&J vaccine along with the Moderna and Pfizer vaccines that were given emergency use authorization will continue. Dr. William Petri, an infectious-disease physician and immunologist at the University of Virginia School of Medicine, explains this development and why the agencies decided that the benefits of the vaccine far outweigh the risks. What was the concern with the Johnson & Johnson COVID-19 vaccine? The FDA and CDC paused the use of the J&J vaccine on...

July 15, 2020 marks 75 years since the detonation of the first nuclear bomb. The Trinity Test, in New Mexico’s Jornada del Muerto desert, proved that the design for the Nagasaki Bomb worked and started the nuclear era. The U.S. tested nuclear bombs for decades. But at the end of the Cold War in 1992, the U.S. government imposed a moratorium on U.S. testing. This was strengthened by the Clinton administration’s decision to sign the Comprehensive Nuclear Test Ban Treaty. Although the Senate never ratified the treaty and it never entered into force, all 184 countries that signed the test ban, including the U.S., have followed its rules. But in recent weeks, the Trump administration and Congress have begun debating whether to restart active testing of nuclear weapons on U.S. soil. Some cons...

Tag: restart

A Doctor Explains Why Benefits Far Outweigh Risks – Restart Of The Johnson & Johnson COVID-19 Vaccine

A restart of nuclear testing offers little scientific value to the US and would benefit other countries